SciTransfer
Organization

INSTYTUT CHEMII FIZYCZNEJ POLSKIEJ AKADEMII NAUK

Polish Academy physical chemistry institute pivoting toward biophysics, biomedical diagnostics, and microfluidics, with strong MSCA coordination experience.

Research institutemultidisciplinaryPL
H2020 projects
10
As coordinator
5
Total EC funding
€8.4M
Unique partners
85
What they do

Their core work

The Institute of Physical Chemistry of the Polish Academy of Sciences (IChF PAN) is a leading Polish research institute specializing in physical chemistry at the intersection of chemistry, physics, and biology. Their work spans soft matter physics, nanoscience, advanced optical diagnostics, and microfluidic technologies for protein engineering. They are particularly active in training the next generation of researchers through Marie Skłodowska-Curie programs, and have built a dedicated department for physical chemistry of biological systems — signaling a deliberate push into life sciences and biomedical applications.

Core expertise

What they specialise in

Soft matter and confined systemsprimary
2 projects

CONIN studied confinement effects on inhomogeneous and ionic systems; METCOPH explored macrocyclic metallocomplexes — both rooted in fundamental physical chemistry.

2 projects

NaMeS built an interdisciplinary nanoscience school covering applications and advanced materials; GOTSolar applied nanoscience to third-generation solar cell efficiency.

Microfluidics and protein engineeringsecondary
1 project

EVOdrops developed droplet microfluidics platforms for directed evolution and large-scale protein library screening.

Biomedical optics and diagnosticsemerging
2 projects

IMCUSTOMEYE applied optical coherence tomography to eye diagnostics; UPRECON used ultrafast photonics to detect amyloid aggregates.

Researcher training and institutional capacity buildingprimary
3 projects

CREATE established a new department, PD2PI developed postdoc-to-PI career pathways, and NaMeS ran an interdisciplinary nanoscience school — all coordinated by IChF PAN.

Evolution & trajectory

How they've shifted over time

Early focus
Nanoscience and physical chemistry
Recent focus
Biophysics and biomedical applications

In their early H2020 period (2015–2018), IChF PAN focused on fundamental physical chemistry: solar cell materials, nanoscience, soft matter confinement, and macrocyclic compounds — classic topics for a physical chemistry institute. From 2018 onward, they shifted markedly toward life sciences and biomedical applications: eye diagnostics, amyloid detection, droplet microfluidics for protein engineering, and bio-based materials. This evolution was deliberate — the CREATE project (their largest, EUR 2.5M) explicitly built a new department for physical chemistry of biological systems, and PD2PI trained researchers to bridge chemistry, physics, biology, and medicine.

IChF PAN is repositioning from a traditional physical chemistry institute toward an interdisciplinary hub where chemistry meets biology and medicine — future partners should expect growing capabilities in biomedical diagnostics, microfluidics, and bio-based materials.

Collaboration profile

How they like to work

Role: consortium_leaderReach: European28 countries collaborated

IChF PAN splits evenly between leading and joining consortia (5 coordinated, 5 as participant), which is unusually balanced — they are comfortable in both roles. With 85 unique partners across 28 countries, they maintain a broad and diverse network rather than relying on a small circle of repeat collaborators. Their heavy use of MSCA schemes (RISE, COFUND, ITN) shows they prioritize researcher mobility and training-oriented partnerships, making them a good fit for capacity-building consortia.

IChF PAN has collaborated with 85 distinct partners across 28 countries, reflecting a genuinely pan-European (and partly global) network built through mobility-oriented MSCA projects that naturally diversify partner geography.

Why partner with them

What sets them apart

IChF PAN combines deep physical chemistry fundamentals with a deliberate institutional pivot into biological and biomedical systems — a combination few Eastern European institutes can match. Their track record of coordinating large MSCA and capacity-building projects (CREATE, NaMeS, PD2PI) makes them an experienced lead partner for training networks and Widening Participation actions. For consortium builders, they offer the rare combination of strong fundamental science, proven coordination capability, and a Polish institutional base that strengthens geographic diversity in proposals.

Notable projects

Highlights from their portfolio

  • CREATE
    Largest project (EUR 2.5M) — created an entirely new department for physical chemistry of biological systems, marking the institute's strategic pivot toward life sciences.
  • PD2PI
    EUR 1.4M COFUND program training postdocs to become independent PIs across chemistry, physics, biology, and medicine — demonstrates institutional commitment to interdisciplinary leadership development.
  • EVOdrops
    Applied droplet microfluidics to directed protein evolution — an unusual and high-impact intersection of physical chemistry with biotechnology and protein engineering.
Cross-sector capabilities
healthdigitalfoodenergy
Analysis note: Despite the HES classification in CORDIS, IChF PAN is a research institute under the Polish Academy of Sciences, not a university. Several projects lack keyword data (METCOPH, UPRECON, CREATE), so expertise mapping for the early period relies partly on project titles and descriptions rather than structured keywords.